{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:44:54Z","timestamp":1774406694399,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41390-021-01548-w","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T13:09:25Z","timestamp":1621429765000},"page":"98-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Integrated analysis of miRNA\u2013mRNA interaction in pediatric dilated cardiomyopathy"],"prefix":"10.1038","volume":"92","author":[{"given":"Frehiwet T.","family":"Hailu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Karimpour-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee S.","family":"Toni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley D.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0349-1776","authenticated-orcid":false,"given":"Carmen C.","family":"Sucharov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"1548_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron, B. J. et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functio. Circulation 113, 1807\u20131816 (2006).","journal-title":"Circulation"},{"key":"1548_CR2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto, Y. M. et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur. Heart J. 37, 1850\u20131858 (2016).","journal-title":"Eur. Heart J."},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.healun.2010.08.009","volume":"29","author":"R Kirk","year":"2010","unstructured":"Kirk, R. et al. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official pediatric heart transplantation report 2010. J. Heart Lung Transplant. 29, 1119\u20131128 (2010).","journal-title":"J. Heart Lung Transplant."},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","volume":"35","author":"SD Miyamoto","year":"2014","unstructured":"Miyamoto, S. D. et al. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur. Heart J. 35, 33\u201341 (2014).","journal-title":"Eur. Heart J."},{"key":"1548_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00059-020-04903-5","volume":"45","author":"C Veltmann","year":"2020","unstructured":"Veltmann, C., Bauersachs, J. & Berliner, D. Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz 45, 212\u2013220 (2020).","journal-title":"Herz"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","volume":"296","author":"JA Towbin","year":"2006","unstructured":"Towbin, J. A. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296, 1867\u20131876 (2006).","journal-title":"JAMA"},{"key":"1548_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/1995-705X.192556","volume":"17","author":"N Jayaprasad","year":"2016","unstructured":"Jayaprasad, N. Heart failure in children. Heart Views 17, 92\u201399 (2016).","journal-title":"Heart Views"},{"key":"1548_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","volume":"33","author":"R Kirk","year":"2014","unstructured":"Kirk, R. et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. J. Heart Lung Transplant. 33, 888\u2013909 (2014).","journal-title":"J. Heart Lung Transplant."},{"key":"1548_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy, R. E. et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298, 1171\u20131179 (2007).","journal-title":"JAMA"},{"key":"1548_CR10","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.jacc.2017.09.1089","volume":"70","author":"RK Singh","year":"2017","unstructured":"Singh, R. K. et al. Survival without cardiac transplantation among children with dilated cardiomyopathy. J. Am. Coll. Cardiol. 70, 2663\u20132673 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1548_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCHEARTFAILURE.114.001218","volume":"8","author":"SJ Nakano","year":"2015","unstructured":"Nakano, S. J. et al. Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy. Circ. Heart Fail. 8, 57\u201363 (2015).","journal-title":"Circ. Heart Fail."},{"key":"1548_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cardfail.2016.11.006","volume":"23","author":"KC Woulfe","year":"2017","unstructured":"Woulfe, K. C. et al. Fibrosis and fibrotic gene expression in pediatric and adult patients with idiopathic dilated cardiomyopathy. J. Card. Fail. 23, 314\u2013324 (2017).","journal-title":"J. Card. Fail."},{"key":"1548_CR13","doi-asserted-by":"publisher","first-page":"e94249","DOI":"10.1172\/jci.insight.94249","volume":"2","author":"PD Tatman","year":"2017","unstructured":"Tatman, P. D. et al. Pediatric dilated cardiomyopathy hearts display a unique gene expression profile. JCI Insight 2, e94249 (2017).","journal-title":"JCI Insight"},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.01.005","volume":"57","author":"BL Stauffer","year":"2013","unstructured":"Stauffer, B. L., Russell, G., Nunley, K., Miyamoto, S. D. & Sucharov, C. C. MiRNA expression in pediatric failing human heart. J. Mol. Cell. Cardiol. 57, 43\u201346 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros, V. microRNAs: tiny regulators with great potential. Cell 107, 823\u2013826 (2001).","journal-title":"Cell"},{"key":"1548_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCRESAHA.108.192872","volume":"104","author":"KR Cordes","year":"2009","unstructured":"Cordes, K. R. & Srivastava, D. MicroRNA regulation of cardiovascular development. Circ. Res. 104, 724\u2013732 (2009).","journal-title":"Circ. Res."},{"key":"1548_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ejhf.495","volume":"18","author":"EL Vegter","year":"2016","unstructured":"Vegter, E. L., van der Meer, P., de Windt, L. J., Pinto, Y. M. & Voors, A. A. MicroRNAs in heart failure: from biomarker to target for therapy. Eur. J. Heart Fail. 18, 457\u2013468 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"1548_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"D Robinson Mark","year":"2010","unstructured":"Robinson Mark, D., McCarthy Davis, J. & Smyth Gordon, K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"1548_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cardfail.2014.09.013","volume":"21","author":"CC Sucharov","year":"2015","unstructured":"Sucharov, C. C. et al. Micro-RNA expression in hypoplastic left heart syndrome. J. Card. Fail. 21, 83\u201388 (2015).","journal-title":"J. Card. Fail."},{"key":"1548_CR21","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1152\/ajpregu.00346.2004","volume":"287","author":"D Curran-Everett","year":"2004","unstructured":"Curran-Everett, D. & Benos, D. J. Guidelines for reporting statistics in journals published by the American Physiological Society. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R247\u2013R249 (2004).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1548_CR22","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, e05005 (2015).","journal-title":"eLife"},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman, R. C., Farh, K. K. H., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92\u2013105 (2009).","journal-title":"Genome Res."},{"key":"1548_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-physiol-030212-183737","volume":"75","author":"A Hata","year":"2013","unstructured":"Hata, A. Functions of microRNAs in cardiovascular biology and disease. Annu. Rev. Physiol. 75, 69\u201393 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"1548_CR25","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.jacc.2014.01.050","volume":"63","author":"G Condorelli","year":"2014","unstructured":"Condorelli, G., Latronico, M. V. & Cavarretta, E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 63, 2177\u20132187 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.17219\/acem\/62915","volume":"26","author":"A Wojciechowska","year":"2017","unstructured":"Wojciechowska, A., Braniewska, A. & Kozar-Kami\u0144ska, K. MicroRNA in cardiovascular biology and disease. Adv. Clin. Exp. Med. 26, 865\u2013874 (2017).","journal-title":"Adv. Clin. Exp. Med."},{"key":"1548_CR27","first-page":"7120","volume":"44","author":"RM Spengler","year":"2016","unstructured":"Spengler, R. M. et al. Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP. Nucleic Acids Res. 44, 7120\u20137131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1548_CR28","doi-asserted-by":"publisher","first-page":"e45105","DOI":"10.1371\/journal.pone.0045105","volume":"7","author":"M Callari","year":"2012","unstructured":"Callari, M. et al. Comparison of microarray platforms for measuring differential microRNA expression in paired normal\/cancer colon tissues. PLoS ONE 7, e45105 (2012).","journal-title":"PLoS ONE"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1261\/rna.1947110","volume":"16","author":"A Git","year":"2010","unstructured":"Git, A. et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16, 991\u20131006 (2010).","journal-title":"RNA"},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"e89169","DOI":"10.1172\/jci.insight.89169","volume":"2","author":"CC Sucharov","year":"2017","unstructured":"Sucharov, C. C. et al. Myocardial microRNAs associated with reverse remodeling in human heart failure. JCI Insight 2, e89169 (2017).","journal-title":"JCI Insight"},{"key":"1548_CR31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.12659\/MSM.896832","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang, W., Liu, M., Guan, Y. & Wu, Q. Hypoxia-responsive Mir-301a and Mir-301b promote radioresistance of prostate cancer cells via downregulating NDRG2. Med. Sci. Monit. 22, 2126\u20132132 (2016).","journal-title":"Med. Sci. Monit."},{"key":"1548_CR32","first-page":"1886","volume":"9","author":"X Xia","year":"2017","unstructured":"Xia, X. et al. Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN. Am. J. Transl. Res. 9, 1886\u20131895 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"1548_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20680-y","volume":"8","author":"JZ Zheng","year":"2018","unstructured":"Zheng, J. Z. et al. Elevated miR-301a expression indicates a poor prognosis for breast cancer patients. Sci. Rep. 8, 2225 (2018).","journal-title":"Sci. Rep."},{"key":"1548_CR34","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4252\/wjsc.v11.i12.1130","volume":"11","author":"LX Zhen","year":"2019","unstructured":"Zhen, L. X. et al. MiR-301a promotes embryonic stem cell differentiation to cardiomyocytes. World J. Stem Cells 11, 1130\u20131141 (2019).","journal-title":"World J. Stem Cells"},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"e0183901","DOI":"10.1371\/journal.pone.0183901","volume":"12","author":"AY Rangrez","year":"2017","unstructured":"Rangrez, A. Y. et al. MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2. PLoS ONE 12, e0183901 (2017).","journal-title":"PLoS ONE"},{"key":"1548_CR36","first-page":"1816","volume":"92","author":"JG Wang","year":"2012","unstructured":"Wang, J. G. et al. Differential expressions of miRNAs in patients with nonvalvular atrial fibrillation. Natl Med. J. China 92, 1816\u20131819 (2012).","journal-title":"Natl Med. J. China"},{"key":"1548_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2018.05.003","volume":"119","author":"Y Tatekoshi","year":"2018","unstructured":"Tatekoshi, Y. et al. Translational regulation by miR-301b upregulates AMP deaminase in diabetic hearts. J. Mol. Cell. Cardiol. 119, 138\u2013146 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1548_CR38","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ejhf.517","volume":"18","author":"FZ Marques","year":"2016","unstructured":"Marques, F. Z., Vizi, D., Khammy, O., Mariani, J. A. & Kaye, D. M. The transcardiac gradient of cardio-microRNAs in the failing heart. Eur. J. Heart Fail. 18, 1000\u20131008 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"1548_CR39","doi-asserted-by":"publisher","first-page":"e0151515","DOI":"10.1371\/journal.pone.0151515","volume":"11","author":"AL Clark","year":"2016","unstructured":"Clark, A. L. et al. miR-410 and miR-495 are dynamically regulated in diverse cardiomyopathies and their inhibition attenuates pathological hypertrophy. PLoS ONE 11, e0151515 (2016).","journal-title":"PLoS ONE"},{"key":"1548_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11658-018-0089-x","volume":"23","author":"X Wang","year":"2018","unstructured":"Wang, X., Jin, H., Jiang, S. & Xu, Y. MicroRNA-495 inhibits the high glucose-induced inflammation, differentiation and extracellular matrix accumulation of cardiac fibroblasts through downregulation of NOD1. Cell. Mol. Biol. Lett. 23, 23 (2018).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"1548_CR41","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis, T. E. et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772\u20132786 (2009).","journal-title":"J. Clin. Invest."},{"key":"1548_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1126\/science.1139089","volume":"316","author":"E van Rooij","year":"2007","unstructured":"van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575\u2013579 (2007).","journal-title":"Science"},{"key":"1548_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphys.2019.00123","volume":"10","author":"S Xue","year":"2019","unstructured":"Xue, S. et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front. Physiol. 10, 123 (2019).","journal-title":"Front. Physiol."},{"key":"1548_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00438-018-1426-5","volume":"293","author":"S Yang","year":"2018","unstructured":"Yang, S. et al. Downregulation of microRNA-17-5p improves cardiac function after myocardial infarction via attenuation of apoptosis in endothelial cells. Mol. Genet. Genomics. 293, 883\u2013894 (2018).","journal-title":"Mol. Genet. Genomics."},{"key":"1548_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1152\/physiolgenomics.00265.2007","volume":"33","author":"GE Haddad","year":"2008","unstructured":"Haddad, G. E. et al. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol. Genomics 33, 267\u2013277 (2008).","journal-title":"Physiol. Genomics"},{"key":"1548_CR46","doi-asserted-by":"publisher","first-page":"e79792","DOI":"10.1371\/journal.pone.0079792","volume":"8","author":"MM Molina-Navarro","year":"2013","unstructured":"Molina-Navarro, M. M. et al. Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS ONE 8, e79792 (2013).","journal-title":"PLoS ONE"},{"key":"1548_CR47","doi-asserted-by":"publisher","first-page":"15891","DOI":"10.3390\/ijms150915891","volume":"15","author":"D Joladarashi","year":"2014","unstructured":"Joladarashi, D., Thandavarayan, R. A., Babu, S. S. & Krishnamurthy, P. Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int. J. Mol. Sci. 15, 15891\u201315911 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"1548_CR48","doi-asserted-by":"publisher","first-page":"e0177988","DOI":"10.1371\/journal.pone.0177988","volume":"12","author":"M Tsuji","year":"2017","unstructured":"Tsuji, M. et al. Sexual dimorphisms of mRNA and miRNA in human\/murine heart disease. PLoS ONE 12, e0177988 (2017).","journal-title":"PLoS ONE"},{"key":"1548_CR49","doi-asserted-by":"publisher","unstructured":"Ge, L. et al. miR-181c-5p exacerbates hypoxia\/reoxygenation-induced cardiomyocyte apoptosis via targeting PTPN4. Oxid. Med. Cell. Longev. https:\/\/doi.org\/10.1155\/2019\/1957920 (2019).","DOI":"10.1155\/2019\/1957920"},{"key":"1548_CR50","first-page":"7913418","volume":"2020","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. MiR-181c-5p promotes inflammatory response during hypoxia\/reoxygenation injury by downregulating protein tyrosine phosphatase nonreceptor type 4 in H9C2 cardiomyocytes. Oxid. Med. Cell. Longev. 2020, 7913418 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1548_CR51","first-page":"e24352","volume":"2","author":"FA Zouein","year":"2013","unstructured":"Zouein, F. A., Kurdi, M. & Booz, G. W. Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart. JAKSTAT 2, e24352 (2013).","journal-title":"JAKSTAT"},{"key":"1548_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fcvm.2015.00036","volume":"2","author":"FA Zouein","year":"2015","unstructured":"Zouein, F. A. et al. Pivotal importance of STAT3 in protecting the heart from acute and chronic stress: new advancement and unresolved issues. Front. Cardiovasc. Med. 2, 36 (2015).","journal-title":"Front. Cardiovasc. Med."},{"key":"1548_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2005.02.003","volume":"107","author":"D Hilfiker-Kleiner","year":"2005","unstructured":"Hilfiker-Kleiner, D., Hilfiker, A. & Drexler, H. Many good reasons to have STAT3 in the heart. Pharmacol. Ther. 107, 131\u2013137 (2005).","journal-title":"Pharmacol. Ther."},{"key":"1548_CR54","doi-asserted-by":"publisher","first-page":"e9532","DOI":"10.1371\/journal.pone.0009532","volume":"5","author":"TA Sarafian","year":"2010","unstructured":"Sarafian, T. A. et al. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS ONE 5, e9532 (2010).","journal-title":"PLoS ONE"},{"key":"1548_CR55","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn, J. et al. Function of mitochondrial Stat3 in cellular respiration. Science 323, 793\u2013797 (2009).","journal-title":"Science"},{"key":"1548_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.yjmcc.2014.06.002","volume":"74","author":"KC Chatfield","year":"2014","unstructured":"Chatfield, K. C. et al. Dysregulation of cardiolipin biosynthesis in pediatric heart failure. J. Mol. Cell. Cardiol. 74, 251\u2013259 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1548_CR57","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507\u20131546 (2010).","journal-title":"Physiol. Rev."},{"key":"1548_CR58","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s001090050275","volume":"76","author":"PH Sugden","year":"1998","unstructured":"Sugden, P. H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725\u2013746 (1998).","journal-title":"J. Mol. Med."},{"key":"1548_CR59","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/cbin.11053","volume":"42","author":"B Yu","year":"2018","unstructured":"Yu, B. et al. Inhibition of microRNA-143-3p attenuates myocardial hypertrophy by inhibiting inflammatory response. Cell Biol. Int. 42, 1584\u20131593 (2018).","journal-title":"Cell Biol. Int."},{"key":"1548_CR60","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0008-6363(00)00142-5","volume":"47","author":"JK Dam\u00e5s","year":"2000","unstructured":"Dam\u00e5s, J. K. et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc. Res. 47, 778\u2013787 (2000).","journal-title":"Cardiovasc. Res."},{"key":"1548_CR61","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.yjmcc.2006.08.008","volume":"41","author":"RT Pyo","year":"2006","unstructured":"Pyo, R. T. et al. CXCR4 modulates contractility in adult cardiac myocytes. J. Mol. Cell. Cardiol. 41, 834\u2013844 (2006).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1548_CR62","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/ijms20092267","volume":"20","author":"TJ LaRocca","year":"2019","unstructured":"LaRocca, T. J. et al. CXCR4 cardiac specific knockout mice develop a progressive cardiomyopathy. Int. J. Mol. Sci. 20, 2269 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1548_CR63","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/eji.201646557","volume":"46","author":"NL Diny","year":"2016","unstructured":"Diny, N. L. et al. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur. J. Immunol. 46, 2749\u20132760 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1548_CR64","doi-asserted-by":"publisher","first-page":"e94382","DOI":"10.1172\/jci.insight.94382","volume":"2","author":"MD Patel","year":"2017","unstructured":"Patel, M. D. et al. Pediatric and adult dilated cardiomyopathy represent distinct pathological entities. JCI Insight 2, e94382 (2017).","journal-title":"JCI Insight"},{"key":"1548_CR65","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen, T. et al. Hippo pathway inhibits wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458\u2013461 (2011).","journal-title":"Science"},{"key":"1548_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fcell.2019.00211","volume":"7","author":"MM Mia","year":"2019","unstructured":"Mia, M. M. & Singh, M. K. The Hippo signaling pathway in cardiac development and diseases. Front. Cell Dev. Biol. 7, 211 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"1548_CR67","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"M Xin","year":"2013","unstructured":"Xin, M. et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl Acad. Sci. USA 110, 13839\u20131383944 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1548_CR68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.athoracsur.2015.04.088","volume":"100","author":"B Wehman","year":"2015","unstructured":"Wehman, B. et al. Pediatric end-stage failing hearts demonstrate increased cardiac stem cells. Ann. Thorac. Surg. 100, 615\u2013622 (2015).","journal-title":"Ann. Thorac. Surg."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01548-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01548-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01548-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T16:04:03Z","timestamp":1661443443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01548-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01548-w","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C.S. and M.R.B.: scientific founder and shareholder at miRagen Inc. C.C.S., S.D.M., and B.L.S.: scientific founders and shareholders at CoramiR Inc. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All subjects gave informed consent and donated their hearts to the institutional review board-approved Investigations of Pediatric or Adult heart tissue bank at the University of Colorado, Denver.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of consent"}}]}}